Skp2 deficiency inhibits chemical skin tumorigenesis independent of p27(Kip1) accumulation.
Skp2 deficiency inhibits chemical skin tumorigenesis independent of p27(Kip1) accumulation.
复制标题
DOI:
10.1016/j.ajpath.2013.01.016
复制
发表时间:
2013-05
期刊:
影响因子:
--
通讯作者:
Christopher Sistrunk;Sun Hye Kim;Xian Wang;Sung Hyun Lee;Yongbaek Kim;Everardo Macias;M. Rodriguez-Puebla
中科院分区:
文献类型:
--
作者:
Christopher Sistrunk;Sun Hye Kim;Xian Wang;Sung Hyun Lee;Yongbaek Kim;Everardo Macias;M. Rodriguez-Puebla
S-phase kinase-associated protein 2 (Skp2) functions as the receptor component of the Skp–Cullin–F-box complex and is implicated in the degradation of several cell cycle regulators, such as p21Cip1, p27Kip1, p57Kip2, and cyclin E. Numerous studies in human and experimental tumors have demonstrated low p27Kip1levels and elevated Skp2 expression. However, a direct association between the inverse correlation of Skp2 and p27Kip1with tumorigenesis has not been demonstrated. Herein, we provide evidence that skin tumorigenesis is inhibited inSkp2−/−mice. An analysis of mouse keratinocytes indicates that increased p27Kip1levels inSkp2−/−epidermis cause reduced cell proliferation that is alleviated in the epidermis fromSkp2−/−/p27−/−compound mice. In contrast, we establish that a p27Kip1deficiency does not overturn the reduced skin tumorigenesis experienced bySkp2−/−mice. In addition,Skp2−/−epidermis exhibits an accumulation of p53-cofactor CBP/p300 that is associated with elevated apoptosis in hair follicles and decreased skin tumorigenesis. We conclude that p27Kip1accumulation is responsible for the hypoplasia observed in normal tissues ofSkp2−/−mice but does not have a preponderant function in reducing skin tumorigenesis.